Mejías, Asunción <br/><br/>
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  May 2004 
 - 1811-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.48.5.1811-1822.2004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Airway Obstruction--etiology<br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Viral--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Bronchial Hyperreactivity--etiology<br/>Bronchoalveolar Lavage Fluid--chemistry<br/>Cell Line<br/>Chemokines--metabolism<br/>Cytokines--metabolism<br/>Humans<br/>Lung--pathology<br/>Mice<br/>Mice, Inbred BALB C<br/>Palivizumab<br/>Plethysmography, Whole Body<br/>Pneumonia--drug therapy<br/>Respiratory Function Tests<br/>Respiratory Syncytial Virus Infections--complications<br/>Tissue Fixation